§ 1746. Emergency Contraception.
16 CA ADC § 1746Barclays Official California Code of Regulations
16 CCR § 1746
§ 1746. Emergency Contraception.
(1) Authority: Section 4052.3(a)(2) of the California Business and Professions Code authorizes a pharmacist to furnish emergency contraception pursuant to a protocol approved by the California State Board of Pharmacy and the Medical Board of California. Use of the protocol specified in this section satisfies that requirement.
• Are you allergic to any medications?
• Timing is an essential element of the product's effectiveness. EC should be taken as soon as possible after unprotected intercourse. Treatment may be initiated up to five days (120 hours) after unprotected intercourse.
EC use will not interfere with an established or implanted pregnancy.
If more than 72 hours have elapsed since unprotected intercourse, the use of ellaTM (ulipristal) may be more effective than levonorgestrel. For other options for EC, consult with your health care provider.
Please follow up with your health care provider after the use of EC.
Fact Sheet: The pharmacist will provide the patient with a copy of the current EC fact sheet approved by the Board of Pharmacy as required by Business and Professions Code Section 4052.3(e).
(5) Referrals and Supplies: If emergency contraception services are not immediately available at the pharmacy or the pharmacist declines to furnish pursuant to conscience clause, the pharmacist will refer the patient to another emergency contraception provider. The pharmacist shall comply with all state mandatory reporting laws, including sexual abuse laws.
(8) EC Product Selection: The pharmacist will provide emergency contraception medication from the list of products specified in this protocol. This list must be kept current and maintained in the pharmacy. Along with emergency contraception products, the list will include adjunctive medications indicated for nausea and vomiting associated with taking EC containing estrogen. Patients will be provided information concerning dosing and potential adverse effects.
Dedicated Approved Products for Emergency Contraception |
Brand | Dose | Ethinyl Estradiol per dose (mcg) |
One Tablet Regimens |
Plan BTM One-Step | 1 tablet | 0 | 1.5mg levonorgestrel | |
ellaTM | 1 tablet | 0 | 30mg ulipristal | |
Levonorgestrel | 1 tablet | 0 | 1.5mg levonorgestrel | |
Two Tablet Regimens |
Next ChoiceTM | 2 tablets at once (1.5mg total dose) or 1 tablet (0.75mg) followed by 1 tablet (0.75mg) 12 hours later | 0 | Each tablet is 0.75 mg levonorgestrel | |
Levonorgestrel | 2 tablets at once (1.5mg total dose) or 1 tablet (0.75mg) followed by 1 tablet (0.75mg) 12 hours later | 0 | Each tablet is 0.75 mg levonorgestrel |
Oral Contraceptive Pills |
---|
Brand | Tablets per Dose | Ethinyl Estradiol | Levonorgestrel |
---|
(two doses 12 hours apart*) | per dose (mcg) | per dose (mg)* |
---|
Alesse | 5 pink tablets | 100 | 0.50 |
Aviane | 5 orange tablets | 100 | 0.50 |
Levlen | 4 light-orange tablets | 120 | 0.60 |
Levlite | 5 pink tablets | 100 | 0.50 |
Levora | 4 white tablets | 120 | 0.60 |
Lo/Ovral | 4 white tablets | 120 | 0.50 |
Low-Ogestrel | 4 white tablets | 120 | 0.60 |
Nordette | 4 light-orange tablets | 120 | 0.60 |
Ogestrel | 2 white tablets | 100 | 0.50 |
Ovral | 2 white tablets | 100 | 0.50 |
Tri-Levlen | 4 yellow tablets | 100 | 0.50 |
Triphasil | 4 yellow tablets | 120 | 0.50 |
Trivora | 4 pink tablets | 120 | 0.50 |
Ovrette | 20 yellow tablets | 0 | 0.75 |
* The progestin in Ovral, Lo/Ovral, and Ovrette is norgestrel, which contains two isomers, only one of which (levonorgestrel) is bioactive; the amount of norgestrel in each dose is twice the amount of levonorgestrel. |
In addition to the products specified in this paragraph, generic equivalent products may be furnished. Estrogen containing regimens are not preferred and should be used only when the other options are not available. |
Non-Prescription Drugs | Dose | Timing of Administration |
Meclizine hydrochloride (Dramamine II, Bonine) | One or two 25 mg tablets | 1 hour before first EC dose; Repeat if needed in 24 hours |
Diphenhydramine hydrochloride (Benadryl) | One or two 25 mg tablets or capsules | 1 hour before first EC dose; repeat as needed every 4-6 hours |
Dimenhydrinate (Dramamine) | One or two 50 mg tablets or 4-8 teaspoons liquid | 30 minutes to 1 hour before first EC dose; repeat as needed every 4-6 hours |
Cyclizine hydrochloride (Marezine) | One 50 mg tablet | 30 minutes before first EC dose; repeat as needed every 4-6 hours |
Credits
Note: Authority cited: Section 4005, Business and Professions Code. Reference: Sections 4052 and 4052.3, Business and Professions Code.
History
1. New section filed 11-2-2004; operative 12-2-2004 (Register 2004, No. 45). For prior history, see Register 80, No. 8.
2. Change without regulatory effect amending subsections (a) and (b)(1) and amending Note filed 12-18-2007 pursuant to section 100, title 1, California Code of Regulations (Register 2007, No. 51).
3. Amendment filed 3-13-2013; operative 7-1-2013 (Register 2013, No. 11).
This database is current through 4/19/24 Register 2024, No. 16.
Cal. Admin. Code tit. 16, § 1746, 16 CA ADC § 1746
End of Document |